Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115370) titled 'A clinical study of ruxolitinib combined with reduced-dose HLH-1994 regimen in the treatment of adult hemophagocytic lymphohistiocytosis' on Dec. 25, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shandong Provincial Qianfoshan Hospital
Condition:
hemophagocytic lymphohistiocytosis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-29
Target Sample Size: Intervention group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=284895
Published by HT Digital Content Services with permission...